NCT04900285

Brief Summary

This research study proposes to determine how well tolerated and effective lower and upper oral dental devices are at reducing snoring. The device is designed to move the genioglossus muscle forward, with interior attachment to maintain forward placement of of he tongue on the bottom of the mouth.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 25, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 6, 2022

Status Verified

April 1, 2022

Enrollment Period

2.6 years

First QC Date

May 13, 2021

Last Update Submit

April 5, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Intensity of Snoring (Snore Lab App; range from Quiet to Epic snoring, Epic is a worse outcome)

    To determine if use of a device to position the tongue forward will decrease the intensity of snoring.

    Daily up to 15 days

  • Frequency of Snoring (Snore Lab App, app records snoring through the night)

    To determine if use of a device to position the tongue forward will decrease the frequency of snoring.

    Daily up to 15 days

Secondary Outcomes (9)

  • Partner Assessment of Snoring (Snore Outcomes Survey, response scale varies per item)

    Day 5 (end of no device use)

  • Partner Assessment of Snoring (Snore Outcomes Survey, response scale varies per item)

    Day 10 (end of lower device use)

  • Partner Assessment of Snoring (Snore Outcomes Survey, response scale varies per item)

    Day 15 (end of lower and upper device use)

  • Device Tolerance and Comfort (Tolerance Form)

    Day 5 (end of no device use)

  • Device Tolerance and Comfort (Tolerance Form)

    Day 10 (end of lower device use)

  • +4 more secondary outcomes

Study Arms (1)

Dental Device Arm

OTHER

Subjects in this single arm study serve as their own control by recording snoring on the SnoreLab device for five days and completing the Snore Outcomes survey. After five nights with now device, the lower dental device is used for five nights and snoring is recorded in the SnoreLab app. At the end of the five nights the subjects complete the Comfort and Difficulties Form and the bed partner completes the Snore Outcomes Survey. If the lower device was tolerated well, the process is repeated with the upper dental device used with the lower device.

Device: Delta Dental Oral Device

Interventions

The oral device is designed to move the genioglossus forward, with interior attachments to maintain the placement of the tongue on the floor of the mouth forward. In addition, bite plates made of the Ethylene-vinyl acetate (EVA) plastic were fabricated and embedded with the mouthpiece to encourage subjects to bite down and push the tongue under the interior lower attachment. The upper plate is made of the same material and slightly opens the bite to improve oral air flow further. The primary component of the mouthpiece is fabricated with Vistamaxx material, which is semi-crystalline 2mm co-polymer that can be molded by the user with Nurse assistance to provide a custom fit. The subject will be fitted by moistening and heating in a microwave. Tthe research staff member will assist to ensure proper fit with both the lower and upper dental devices. The subject then completes the data collection portion regarding using the SnoreLab app and survey completion as previously described.

Dental Device Arm

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to provide informed consent
  • Age 18 or older
  • Self-report of snoring problems
  • Has a bed partner that is willing and able to consent as well as answer questions related to partner's snoring both with and without oral device-

You may not qualify if:

  • Missing teeth.
  • Respiratory disorders requiring treatment including asthma, COPD
  • Poor dental health including gum disease or loose teeth
  • Dental implants placed within the last three months
  • Temporomandibular joint dysfunction
  • Presence of mouth or jaw pain
  • Bruxism (teeth grinding)
  • Full dentures
  • No bed partner
  • Braces
  • Diagnosed with Obstructive or Central Sleep Apnea, Sleep Apnea
  • Uncontrolled RLS
  • Ongoing or prior use of a dental device
  • Noise in bedroom i.e., fan, bed partner snoring
  • Other medical or sleep issues which will interfere with the device per PI discretion
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norton Clinical Research Group

Louisville, Kentucky, 40218, United States

RECRUITING

Related Publications (7)

  • American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

    BACKGROUND
  • Gliklich RE, Wang PC. Validation of the snore outcomes survey for patients with sleep-disordered breathing. Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):819-24. doi: 10.1001/archotol.128.7.819.

    PMID: 12117343BACKGROUND
  • Meira e Cruz M., Cardiovascular Center of University of Lisbon, Lisbon School of Medicine, Lisbon, Portugal; Email: mcruz@medicina.ulisboa.pt

    BACKGROUND
  • Cooke ME, Battagel JM. A thermoplastic mandibular advancement device for the management of non-apnoeic snoring: a randomized controlled trial. Eur J Orthod. 2006 Aug;28(4):327-38. doi: 10.1093/ejo/cji122. Epub 2006 Jun 13.

  • Deeb R, Judge P, Peterson E, Lin JC, Yaremchuk K. Snoring and carotid artery intima-media thickness. Laryngoscope. 2014 Jun;124(6):1486-91. doi: 10.1002/lary.24527. Epub 2014 Jan 28.

  • Johnston CD, Gleadhill IC, Cinnamond MJ, Peden WM. Oral appliances for the management of severe snoring: a randomized controlled trial. Eur J Orthod. 2001 Apr;23(2):127-34. doi: 10.1093/ejo/23.2.127.

  • Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. J Clin Sleep Med. 2015 Jul 15;11(7):773-827. doi: 10.5664/jcsm.4858.

MeSH Terms

Conditions

Snoring

Condition Hierarchy (Ancestors)

Respiratory SoundsSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • David Winslow, MD

    Norton Healthcare

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Subject serve as their own control sleeping without the device for five days and recording snoring on the SnoreLab app and filling out the Snore Outcomes Survey. The lower dental device is used for five days while recording snoring. The subject will then complete the Comfort and Difficulties Form and the bed partner completes the Snore Outcomes Survey. The process is repeated with the upper device for those who tolerate the lower device. use.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pulmonologist, Staff Physician

Study Record Dates

First Submitted

May 13, 2021

First Posted

May 25, 2021

Study Start

June 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

April 6, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

No, this is a limited feasibility study and data will not be generalizable to the public due to small sample size. (n=30)

Locations